La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Aquestive Therapeutics a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Aquestive Therapeutics..

Aquestive Therapeutics (NASDAQ:AQST) Azioni, Catena delle Opzioni

AQUESTIVE THERAPEUTICS INC

Aquestive Therapeutics

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Aquestive Therapeutics, Inc. - Common Stock

Aquestive Therapeutics Inc

Investing in Innovation: Four Small-Caps Driving the Future of Pain Therapy

News

Press Releases

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism

General

Aquestive Therapeutics Provides International Expansion Update for Anaphylm™ (epinephrine) Sublingual Film

Management

Aquestive Therapeutics Names Sherry Korczynski as Chief Commercial Officer

Aquestive Therapeutics to Report Second Quarter 2025 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET

Earnings

Aquestive Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Financing

Aquestive Therapeutics Announces $75M Strategic Funding Agreement with RTW to Support the Potential Launch of Anaphylm™ (epinephrine) Sublingual Film

IPOs

Aquestive Therapeutics Announces Pricing of $85 Million Underwritten Offering of Common Stock

Aquestive Therapeutics to Participate in Upcoming September Investor Conferences

Health Care

Aquestive Therapeutics Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for Anaphylm™

AQST

ASRT

COLL

NTRB

Alumis

ALT5 Sigma

Arvinas

Canopy Growth Corporation - Common Shares

Canopy Growth

Collegium Pharmaceutical, Inc. - Common Stock

Collegium Pharmaceutical

Cormedix

Cronos Group

Evolus

Esperion Therapeutics, Inc. - Common Stock

Esperion Therapeutics

Eton Pharmaceuticals, Inc. - Common Stock

Eton Pharmaceuticals

EyePoint Pharmaceuticals, Inc. - Common Stock

EyePoint Pharmaceuticals

Fulcrum Therapeutics, Inc. - Common Stock

Fulcrum Therapeutics

GH Research

LB Pharmaceuticals

MBX Biosciences

Mind Medicine (MindMed) Inc. - Common Shares

Mind Medicine

Oculis Holding

Phathom Pharmaceuticals, Inc. - Common Stock

Phathom Pharmaceuticals

Septerna

SIGA Technologies

SNDL

Theravance Biopharma, Inc. - Ordinary Shares

Theravance Biopharma

Terns Pharmaceuticals, Inc. - Common Stock

Terns Pharma

Tvardi Therapeutics

Zevra Therapeutics

Oppenheimer

HC Wainwright & Co.

Lake Street

Cantor Fitzgerald

Comments

Aquestive Therapeutics

Aquestive Therapeutics (AQST) Opzioni

Aquestive Therapeutics (NASDAQ:AQST) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO